Corcept Therapeutics CORT announced that the FDA has issued a complete response letter (“CRL”) to its new drug application ...

Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy ...

Researchers have investigated the role that estrogen plays in signaling more gut pain, and it isn't working alone.

It’s no wonder hormone imbalances are so common these days. We are exposed to between 80,000 to 100,000 synthetic toxic ...

LIV Hospital International has released an informational overview outlining the clinical role of hormone therapy in the ...

“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...

Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...

Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.

Waymo is rapidly expanding, processing over 450,000 paid rides per week, and is reportedly in talks to raise over $15 billion ...

The hormone estrogen—which female animals typically have more of than males—triggers a molecular cascade in the gut that ...

In the expanding field of peptide-based research, a combination of two bioactive molecules—BPC‑157 and TB‑500—has garnered ...

Tesamorelin is a synthetic 44–amino acid analog of growth hormone–releasing hormone (GHRH) that has attracted attention outside the experimental domain for its potential as a research tool. This ...